Cytokine Storm in COVID-19: Exploring IL-6 Signaling and Cytokine-Microbiome Interactions as Emerging Therapeutic Approaches
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(21), P. 11411 - 11411
Published: Oct. 24, 2024
IL-6
remains
a
key
molecule
of
the
cytokine
storms
characterizing
COVID-19,
exerting
both
proinflammatory
and
anti-inflammatory
effects.
Emerging
research
underscores
significance
trans-signaling
over
classical
signaling
pathways,
which
has
shifted
focus
therapeutic
strategies.
Additionally,
synergistic
action
TNF-α
IFN-γ
been
found
to
induce
inflammatory
cell
death
through
PANoptosis,
further
amplifying
severity
storms.
Long
COVID-19
patients,
as
well
those
with
triggered
by
other
conditions,
exhibit
distinct
laboratory
profiles,
indicating
need
for
targeted
approaches
diagnosis
management.
Growing
evidence
also
highlights
gut
microbiota's
crucial
role
in
modulating
immune
response
during
affecting
production,
adding
complexity
disease's
immunological
landscape.
Targeted
intervention
strategies
should
on
specific
cutoffs,
though
accurate
quantification
clinical
challenge.
Current
treatment
are
increasingly
focused
inhibiting
trans-signaling,
offers
promise
more
precise
manage
hyperinflammatory
responses
COVID-19.
In
light
recent
discoveries,
this
review
summarizes
findings
storms,
particularly
their
conditions.
It
explores
emerging
targeting
cytokines
like
IL-6,
TNF-α,
IFN-γ,
while
addressing
open
questions,
such
better
biomarkers
detect
ongoing
challenges
developing
treatments
that
mitigate
hyperinflammation
without
compromising
function,
emphasizing
importance
continued
field.
Language: Английский
Immunomodulation in Non-traditional Therapies for Methicillin-resistant Staphylococcus aureus (MRSA) Management
Suthi Subbarayudu,
No information about this author
S. Karthick Raja Namasivayam,
No information about this author
Jesu Arockiaraj
No information about this author
et al.
Current Microbiology,
Journal Year:
2024,
Volume and Issue:
81(10)
Published: Sept. 6, 2024
Language: Английский
Exploring the Potential of Dietary Supplements to Alleviate Pain Due to Long COVID
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(7), P. 1287 - 1287
Published: April 7, 2025
Long
COVID,
characterized
by
persistent
symptoms
following
COVID-19
infection,
significantly
impacts
individuals'
health
and
daily
functioning
due
to
fatigue
pain.
Focusing
on
pain,
this
review
addresses
nociplastic
chronic
pain
conditions.
Interventions
designed
reduce
inflammation,
oxidative
stress,
enhance
vagal
activity
may
offer
a
promising
approach
managing
post-pandemic
This
presents
individual
components
of
food
supplements
with
demonstrated
efficacy
in
one
or
more
conditions,
focusing
their
proposed
mechanisms
clinical
including
use
post-COVID-19
when
available.
Many
these
substances
have
long
history
safe
an
alternative
long-term
analgesic
drug
treatment,
which
is
often
associated
potential
side
effects.
also
explores
the
for
synergistic
effects
combining
each
other
conventional
analgesics,
considering
advantages
both
patients
healthcare
system
using
as
adjunctive
primary
therapies
related
COVID.
While
preclinical
scientific
literature
provides
mechanistic
basis
action
several
control
signaling
pathways,
experience,
particularly
field
COVID-associated
still
limited.
However,
reviewed
strongly
suggests
that
attainable
goal,
provided
rigorous
trials
are
conducted.
Language: Английский
The Prevention of Viral Infections: The Role of Intestinal Microbiota and Nutritional Factors
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(15), P. 2445 - 2445
Published: July 27, 2024
Viral
infections
pose
significant
global
challenges
due
to
their
rapid
transmissibility.
Therefore,
preventing
and
treating
these
promptly
is
crucial
curbing
spread.
This
review
focuses
on
the
vital
link
between
nutrition
viral
infections,
underscoring
how
dietary
factors
influence
immune
system
modulation.
Malnutrition,
characterized
by
deficiencies
in
essential
nutrients
such
as
vitamins
A,
C,
D,
E,
zinc,
can
impair
system,
thereby
increasing
vulnerability
potentially
leading
more
severe
health
outcomes
that
complicate
recovery.
Additionally,
emerging
evidence
highlights
role
of
commensal
microbiota
regulation,
which
affect
hosts’
susceptibility
infections.
Specific
components,
including
bioactive
compounds,
vitamins,
probiotics,
beneficially
modify
gut
microbiota,
thus
enhancing
response
offering
protection
against
aims
elucidate
mechanisms
adjustments
impact
pathogenesis
with
a
particular
focus
strengthening
system.
Language: Английский
The Interplay of Microbiota, Long COVID, and Musculoskeletal Pain: A Narrative Review
Leila Simorgh,
No information about this author
Rozita Hedayati,
No information about this author
Mina Sadat Mirshoja
No information about this author
et al.
Deleted Journal,
Journal Year:
2024,
Volume and Issue:
1(2)
Published: Sept. 1, 2024
Context:
Long
COVID,
a
condition
that
persists
after
the
acute
phase
of
COVID-19,
poses
significant
burden,
with
10
-
45%
recovered
patients
experiencing
persistent
symptoms.
Among
these,
approximately
46%
report
musculoskeletal
pain.
This
narrative
review
explores
potential
connections
between
gut
microbiota,
and
pain,
aiming
to
introduce
new
therapeutic
avenues
preventive
strategies
for
managing
symptoms
in
COVID
patients.
Evidence
Acquisition:
A
comprehensive
search
was
conducted
using
Google
Scholar,
Lens.org,
ConnectedPaper.com
identify
relevant
articles
published
2019
2024.
Keywords
related
pain
were
used.
Articles
selected
based
on
predefined
inclusion
exclusion
criteria,
their
quality
assessed.
Data
from
synthesized
provide
an
overview
interplay
Results:
Recent
research
highlights
role
microbiota
modulating
immune
responses
systemic
inflammation.
Dysbiosis
has
been
linked
severity
progression
COVID-19
persistence
Individuals
often
experience
new-onset
manifestations,
such
as
joint
myalgia,
chronic
Additionally,
dysbiosis
associated
conditions
like
lower
back
knee
osteoarthritis.
suggests
relationship
problems
general
may
also
extend
patients,
indicating
broader
implications
outcomes.
Therapeutic
targeting
probiotics,
prebiotics,
dietary
interventions,
have
shown
promise
these
improving
overall
health
Conclusions:
The
evidence
underscores
importance
understanding
microbiota-musculoskeletal
nexus
COVID.
Gut
contributes
inflammation,
exacerbating
associations
other
emphasize
need
microbiota-targeted
strategies.
Future
should
focus
elucidating
mechanisms
linking
exploring
gut-brain
axis,
developing
personalized
approaches
modulate
microbiota.
Advancing
our
this
can
pave
way
innovative
address
complex
challenges
posed
by
conditions.
Language: Английский